Document is current
Any future updates will be listed below
-
Authors
Ichikado, Kazuya
Ichiyasu, Hidenori
Iyonaga, Kazuhiro
Kawamura, Kodai
Yasuda, Yuko
Anan, Keisuke
Okabayashi, Hiroko
Akaike, Kimitaka
Higashi, Noritaka
Johkoh, Takeshi
Fujimoto, Kiminori
Saito, Tetsuo
Morinaga, Jun
Yoshida, Minoru
Mitsuzaki, Katsuhiko
Sakagami, Takuro
- License Information
-
More Information
Article History
Received: 1 October 2024
Accepted: 22 January 2025
First Online: 29 January 2025
Declarations
:
: This study complied with the Helsinki Declaration and the protocol, and the informed consent forms were approved by the Institutional Review Boards of Kumamoto University Hospital (approval number: 2368), Saiseikai Kumamoto Hospital (approval number: 809), and Kumamoto Red Cross Hospital (approval number: 464). Written informed consent was obtained from all participants. Patient recruitment commenced on 20 June 2022.
: Consent for publication was obtained from all participants and authors.
: KI, HI, TJ, and TS received lecture fees from Nippon Boehringer Ingelheim Co. Ltd. Boehringer Ingelheim had no role in the design, analysis, or interpretation of the results in this study. Boehringer Ingelheim was given the opportunity to review the manuscript for medical and scientific accuracy as it relates to Boehringer Ingelheim substances, as well as intellectual property considerations.KI, KK, YY, KA, HO, KA, NH, KF, TS, JM, MY, and KM declare no conflict of interest.
